medigraphic.com
ISSN 1665-3254 (Print)
Revista Oficial de la Universidad Biomédica Rafael Guízar y Valencia A. C.

2021, Number 1

<< Back

Plasticidad y Restauración Neurológica 2021; 8 (1)

Vitamin D deficiency. Current concepts

Sánchez RD, Aguilar RF

Language: Spanish
References: 24
Page: 50-53
PDF size: 192.61 Kb.


ABSTRACT

Background: Vitamin D is a liposoluble hormone that exists in two molecular forms. Ergocalciferol (vitamin D-2) and colecalciferol (vitamin D-3). Vitamin D-3 is produced in the skin by the action of UV-B radiation. Both forms are metabolized by the liver to 25-hydroxy-Vit D (25OHD) and later in the kidney to the active form 1,25-dihydroxy-Vit D. This form promotes bone mineralization by intestinal absorption of calcium and phosphate. Normal levels of 25OHD are associated with less fracture, normal neuromuscular and immune function and possibly have a preventive effect on certain types of cancer. Recommends that optimal plasma levels of 25OHD are above 30 ng/mL, insufficiency between 21 and 29 ng/mL and deficiency below 20 ng/mL. Results: The prevalence rate of 25OHD deficit is about 2 to 90% in different populations. Risk factors of Vitamin D deficit like year season, skin pigmentation, sunlight exposition, use of sunblock and inadecuate Vitamin D ingestion, together with different measurement techniques explain the variability of results between epidemiological studies. An important risk group is the health professionals that are not exposed to sunlight. A low vitamin D status, measured as the plasma level of the transport form of vitamin D, 25 (OH) D.


REFERENCES

  1. Norman AW. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr. 1998; 67 (6): 1108-1110.

  2. Trincado MP. Hipovitaminosis D. Rev Med Clin Condes. 2013; 24: 813-817.

  3. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96 (7): 1911-1930.

  4. Vuolo L, Di Somma C, Faggiano A, Colao A. Vitamin D and cancer. Front Endocrinol. 2012; 3: 58.

  5. Sun Q, Shi L, Rimm EB, Giovannucci EL, Hu FB, Manson JE et al. Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr. 2011; 94 (2): 534-542.

  6. Chagas CE, Borges MC, Martini LA, Rogero MM. Focus on vitamin D, inflammation and type 2 diabetes. Nutrients. 2012; 4 (1): 52-67.

  7. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357 (3): 266-281.

  8. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl D et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr. Br J Nutr. 2014; 111 (1): 23-45.

  9. Morales-Torres J. Vitamin D deficiency across Latin America. Osteoporos Int. 2012; 23 (Suppl 4): S464-466.

  10. Oliveri B, Plantalech L, Bagur A, Wittich AC, Rovai G, Pusiol E et al. High prevalence of vitamin D Insufficiency in healthy elderly people living at home in Argentina. Eur J Clin Nutr. 2004; 58: 337-342.

  11. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med. 2006; 260: 245-254.

  12. Saraiva GL, Cendoroglo MS, Ramos LR, Araújo LM, Vieira JG, Maeda SS et al. Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly in patients and living in the community of the city of Sao Paulo, Brazil. Arq Bras Endocrinol Metabol. 2007; 51: 437-442.

  13. Qu G, Li X, Jiang G. An imperative need for research on the role of environmental factors in transmission of novel coronavirus (COVID-19). Environ Sci Technol. 2020; 12: 22-30.

  14. Laird E, Rhodes J, Kenny RA. Vitamin D and in?ammation: potential implications for severity of COVID-19. Ir Med J. 2020; 113: 81.

  15. Sajadi MM, Habibzadeh P, Vintzileos A et al. Temperature, Humidity, and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19. 2020. SSRN Electronic Journal. Available in: https://doi.org/10.2139/ssrn.3550308

  16. Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among black patients and white patients with COVID-19. N Engl J Med. 2020; 382: 2534-2543.

  17. Kohlmeier M. Avoidance of vitamin D de?cienc to slow the COVID-19 pandemic. BMJ Nutr Prev Health. 2020. Available in: https://doi.org/10.1136/bmjnph-2020-000096

  18. Rhodes JM, Subramanian S, Laird E, Kenny RA. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determined severity. Aliment Pharmacol Ther [On Line). 2020; 51 (12): 1434-1437. Available in: https://doi.org/10.1111/apt.15777

  19. Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019; 40: 1109-1151.

  20. Prietl B, Treiber G, Piber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013; 5: 2502-2521.

  21. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immune-modulator. Immunology. 2011; 134 (2): 123-139.

  22. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009; 182 (7): 4289-4295.

  23. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR et al. Toll-like receptor triggering of a vitamin D- mediated human antimicrobial response. Science. 2006; 311: 1770-1773.

  24. Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system-working in harmonyto reduce the risk of infection. Nutrients [On Line]. 2020; 12 (1): 236. Available in: https://doi.org/10.3390/nu12010236




2020     |     www.medigraphic.com